HAO1 | Hydroxyacid oxidase (glycolate oxidase) 1 | Enzymes
| | | | | Tissue enriched |
HIBADH | 3-hydroxyisobutyrate dehydrogenase | Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HMOX1 | Heme oxygenase (decycling) 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
HMOX2 | Heme oxygenase (decycling) 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
HPGD | Hydroxyprostaglandin dehydrogenase 15-(NAD) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | | | Tissue enriched |
HSD17B12 | Hydroxysteroid (17-beta) dehydrogenase 12 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HSD17B6 | Hydroxysteroid (17-beta) dehydrogenase 6 | Enzymes
| | | | | Tissue enriched |
HSD17B8 | Hydroxysteroid (17-beta) dehydrogenase 8 | Enzymes
| | | | | Expressed in all |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enriched |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH3A | Isocitrate dehydrogenase 3 (NAD+) alpha | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
IDH3B | Isocitrate dehydrogenase 3 (NAD+) beta | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH3G | Isocitrate dehydrogenase 3 (NAD+) gamma | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
IVD | Isovaleryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
IYD | Iodotyrosine deiodinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
KDM2A | Lysine (K)-specific demethylase 2A | Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
LDHAL6B | Lactate dehydrogenase A-like 6B | Enzymes
| | | | | Tissue enriched |
LDHB | Lactate dehydrogenase B | Enzymes Plasma proteins
| | | | | Expressed in all |
LDHC | Lactate dehydrogenase C | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
LEPRE1 | Leucine proline-enriched proteoglycan (leprecan) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
LEPREL1 | Leprecan-like 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
LPO | Lactoperoxidase | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MAOB | Monoamine oxidase B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MDH1 | Malate dehydrogenase 1, NAD (soluble) | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
MDH2 | Malate dehydrogenase 2, NAD (mitochondrial) | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ME2 | Malic enzyme 2, NAD(+)-dependent, mitochondrial | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MECR | Mitochondrial trans-2-enoyl-CoA reductase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
MIOX | Myo-inositol oxygenase | Enzymes
| | | | | Tissue enriched |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MT-CO1 | Mitochondrially encoded cytochrome c oxidase I | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MT-ND3 | Mitochondrially encoded NADH dehydrogenase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MTHFD2 | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
NDUFS3 | NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
NDUFV2 | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
NNT | Nicotinamide nucleotide transhydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NOS3 | Nitric oxide synthase 3 (endothelial cell) | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
NQO2 | NAD(P)H dehydrogenase, quinone 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
NSDHL | NAD(P) dependent steroid dehydrogenase-like | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NXN | Nucleoredoxin | Enzymes
| | | | | Expressed in all |